This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Valentin, A. Articles by Bastide, J. M. Search for Related Content PubMed PubMed Citation Articles by Valentin, A. Articles by Bastide, J. M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 06 1996, 1342-1345, Vol 40, No. 6
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Comparative resistance of Candida albicans clinical isolates to fluconazole and itraconazole in vitro and in vivo in a murine model

A Valentin, R Le Guennec, E Rodriguez, J Reynes, M Mallie and JM Bastide
Laboratoire d'Immunologie et Parasitologie, UFR Sciences Pharmaceutiques et Biologiques, Montpellier, France.

Relationships between azole susceptibility and in vivo response to antifungal therapy in a murine model of candidiasis were investigated for Candida albicans isolates sampled from human immunodeficiency virus type 1-positive patients with oropharyngeal candidiasis. The susceptibilities of seven clinical isolates and two reference strains to fluconazole (FCZ) and itraconazole (ITZ) were determined in vitro by the broth microdilution method. Four isolates were resistant to FCZ and ITZ, two were susceptible to both azoles, and three were resistant to FCZ and susceptible to ITZ (dissociated resistance). CD1 mice were inoculated with each isolate and treated with either FCZ or ITZ (drug regimen, 5 mg/kg of body weight twice daily for 5 days). Quantitative cultures of kidneys were performed at the end of the treatment. On the other hand, the survival rates of the mice were followed daily. These two parameters were clearly correlated with in vitro susceptibility. Thus, the phenomenon of a dissociation of resistance to FCZ and ITZ may be found in vivo as well as in vitro.

This article has been cited by other articles:

• Spellberg, B. J., Collins, M., French, S. W., Edwards, J. E. Jr, Fu, Y., Ibrahim, A. S. (2005). A phagocytic cell line markedly improves survival of infected neutropenic mice. J. Leukoc. Biol. 78: 338-344 [Abstract] [Full Text]  
• Ibrahim, A. S., Spellberg, B. J., Avenissian, V., Fu, Y., Filler, S. G., Edwards, J. E. Jr. (2005). Vaccination with Recombinant N-Terminal Domain of Als1p Improves Survival during Murine Disseminated Candidiasis by Enhancing Cell-Mediated, Not Humoral, Immunity. Infect. Immun. 73: 999-1005 [Abstract] [Full Text]  
• MacCallum, D. M., Odds, F. C. (2002). Efficacy of parenteral itraconazole against disseminated Candida albicans infection in two mouse strains. J Antimicrob Chemother 50: 225-229 [Abstract] [Full Text]  
• Walsh, T. J., Gonzalez, C. E., Piscitelli, S., Bacher, J. D., Peter, J., Torres, R., Shetti, D., Katsov, V., Kligys, K., Lyman, C. A. (2000). Correlation between In Vitro and In Vivo Antifungal Activities in Experimental Fluconazole-Resistant Oropharyngeal and Esophageal Candidiasis. J. Clin. Microbiol. 38: 2369-2373 [Abstract] [Full Text]  
• Vazquez, J. A., Arganoza, M. T., Boikov, D., Yoon, S., Sobel, J. D., Akins, R. A. (1998). Stable Phenotypic Resistance of Candida Species to Amphotericin B Conferred by Preexposure to Subinhibitory Levels of Azoles. J. Clin. Microbiol. 36: 2690-2695 [Abstract] [Full Text]